Calgary company offers increased COVID-19 testing capability with versatile CoviLamp
CardiAl CEO Dr. Anmol Kapoor says this would allow AHS to ramp up its current capacity from the average 12,000 to 13,000 daily tests to about 100,000 tests a day
Rapid COVID-19 test -Disrupting medicine for the global good
On this episode of On the Levvel, we learn that Dr. Kapoor’s passion for equality, medicine, and education has made him a disruptor by wanting to streamline the antiquated lab process. His CoviLamp test is an advanced isothermal amplification of the COVID virus.
Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.
Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.
Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.
Philos reader is the world’s first multiport reader capable to read multiple test strip simultaneously to provide users with comprehensive data about their health.
Philos reader is designed for patients to monitor and manage their chronic conditions, including diabetics and cardiovascular ailments.
Philos is a handheld reader that reads the biomarker information from the CardiAI’s electrochemical test strip. Philos has a touch screen interface that allows users to set up their user profile before running a test at the comfort of their homes. The electronics within the device is designed to accept CardiAI Inc’s proprietary strips. On reading the data, the device securely transmits the results to a companion mobile application via Bluetooth, allowing the user to share their health data with their trusted health care professionals.